Treatment Free Survival (TFS) in Patients (pts) with Chronic Myeloid Leukemia (CML) Carrying Atypical BCR-ABL1 Fusion Transcripts: The French CML Group (Fi-LMC) Experience

被引：0
|
作者：
Johnson-Ansah, Hyacinthe [1 ,2 ]
Charbonnier, Aude [1 ,3 ]
Rea, Delphine [4 ,5 ]
Etienne, Gabriel [6 ,7 ,8 ,9 ]
Roy, Lydia [6 ,10 ]
Legros, Laurence [1 ,11 ]
Bresler, Agnes Guerci [12 ]
Bouvier, Anne [13 ]
Cayssials, Emilie [14 ,15 ]
Coiteux, Valerie [16 ]
Rousselot, Philippe [6 ,17 ]
Dulucq, Stephanie [6 ,18 ]
Hayette, Sandrine [6 ,19 ]
Mahon, Francois-Xavier [6 ,20 ]
Nicolini, Franck E. [6 ,21 ,22 ,23 ]
机构：
[1] French Grp CML, Inst Bergonie, Bordeaux, France
[2] CHU Caen Normandie, Inst Hematol Basse Normandie, Caen, France
[3] Inst Paoli Calmettes, Dept Hematol, Marseille, France
[4] Univ Paris, St Louis Hosp, AP HP, Dept Hematol, Paris, France
[5] Fi LMC Grp, Paris, France
[6] Fi LMC Grp, Pessac, France
[7] Hop Haut Leveque, Inst Bergonie, Pessac, France
[8] Hop Haut Leveque, INSERM, Pessac, France
[9] Hop Haut Leveque, Grp France Intergrp Leucemies Myeloides Chron, Pessac, France
[10] Hop Henri Mondor, Dept Hematol, Creteil, France
[11] Hop Paul Brousse, Dept Hematol, Villejuif, France
[12] Ctr Hosp Univ Brabois, Serv Hematol Clin, Nancy, France
[13] Angers Univ Hosp, Angers, France
[14] French Grp CML Fi LMC, Pessac, France
[15] Univ Poitiers Hosp, Poitiers, France
[16] CHRU Lille, Dept Hematol, Lille, France
[17] Ctr Hosp Versailles, Dept Hematol, Le Chesnay, France
[18] Univ Hosp Bordeaux, Hop Haut Leveque, Hematol Lab, Pessac, France
[19] Ctr Hosp Lyon Sud, Pierre Benite, France
[20] Univ Bordeaux, Inst Bergonie, Canc Ctr Bordeaux, INSERM,U1218, Bordeaux, France
[21] Ctr Hosp Lyon Sud, Ctr Leon Berard, Dept Hematol 33, Pierre Benite, France
[22] CRCL, Lyon, France
[23] INSERM, U590, CRCL, Lyon, France
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-147537
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3604
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Recommendations from the French CML Study Group (Fi-LMC) for BCR-ABL1 kinase domain mutation analysis in chronic myeloid leukemia
    Cayuela, Jean-Michel
    Chomel, Jean-Claude
    Coiteux, Valerie
    Dulucq, Stephanie
    Escoffre-Barbe, Martine
    Etancelin, Pascaline
    Etienne, Gabriel
    Hayette, Sandrine
    Millot, Frederic
    Nibourel, Olivier
    Nicolini, Franck-Emmanuel
    Rea, Delphine
    BULLETIN DU CANCER, 2020, 107 (01) : 113 - 128
  • [2] Dynamics of BCR-ABL1 transcripts during nilotinib therapy in patients with chronic myeloid leukemia (CML)
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Jones, Dan
    O'Brien, Susan
    Rios, Mary Beth
    Cortes, Jorge
    BLOOD, 2007, 110 (11) : 870A - 870A
  • [3] Discontinuation of Dasatinib or Nilotinib in Chronic Myeloid Leukemia (CML) Patients (pts) with Stable Undetectable Bcr-Abl Transcripts: Results From the French CML Group (FILMC)
    Rea, Delphine
    Rousselot, Philippe
    Nicolini, Franck E.
    Legros, Laurence
    Tulliez, Michel
    Giraudier, Stephane
    Cony-Makhoul, Pascale
    Guilhot, Francois
    Mahon, Francois-Xavier
    BLOOD, 2011, 118 (21) : 277 - 277
  • [4] Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM)
    Deau, Benedicte
    Montveneur, Mathias
    Coiteux, Valerie
    Renneville, Aline
    Rigal-Huguet, Francoise
    Delabesse, Eric
    Tulliez, Michel
    Bories, Dominique
    Charbonnier, Aude
    Mozziconacci, Marie-Joelle
    Legay, Thibault
    Lippert, Eric
    Mahon, Francois-Xavier
    Rea, Delphine
    Cayuela, Jean-Michel
    Ame, Shanti
    Gaub, Marie-Pierre
    Gardembas, Martine
    Blanchet, Odile
    Audhuy, Bruno
    Buzyn, Agnes
    Mac Intyre, Elisabeth
    Andreoli, Anna-Lisa
    Reman, Oumedaly
    Contentin, Nathalie
    Bastard, Christian
    Ianotto, Jean-Christophe
    Ugo, Valerie
    Kiladjian, Jean-Jacques
    Brahimi, Said
    Dubruille, Viviane
    Brantus, Jean-Francois
    Sobh, Mohamad
    Morisset, Stephane
    Preudhomme, Claude
    Hayette, Sandrine
    Nicolini, Franck E.
    BLOOD, 2010, 116 (21) : 1382 - 1383
  • [5] Treatment-Free Remission in Chronic Myeloid Leukemia Harboring Atypical BCR-ABL1 Transcripts
    Dragani, Matteo
    Petiti, Jessica
    Rege-Cambrin, Giovanna
    Gottardi, Enrico
    Daraio, Filomena
    Caocci, Giovanni
    Aguzzi, Chiara
    Crisa, Elena
    Andreani, Giacomo
    Caciolli, Francesca
    Fava, Carmen
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2020, 12
  • [6] Chronic Myeloid Leukemia with Atypical BCR-ABL1 Fusion Transcripts: Report of Four cases
    Han, Cong
    LABORATORY INVESTIGATION, 2018, 98 : 519 - 519
  • [7] Chronic Myeloid Leukemia with Atypical BCR-ABL1 Fusion Transcripts: Report of Four cases
    Han, Cong
    MODERN PATHOLOGY, 2018, 31 : 519 - 519
  • [8] Quantification of atypical BCR-ABL1 fusion transcripts in patients with chronic myeloid leukemia: Which approach for harmonization?
    Bhreathnach, Una
    Langabeer, Stephen E.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (02) : E67 - E68
  • [9] Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients
    Arun, A. K.
    Senthamizhselvi, A.
    Mani, S.
    Vinodhini, K.
    Janet, N. B.
    Lakshmi, K. M.
    Abraham, A.
    George, B.
    Srivastava, A.
    Srivastava, V. M.
    Mathews, V.
    Balasubramanian, P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (03) : 235 - 242
  • [10] Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group)
    Rea, Delphine
    Cayassials, Emilie
    Charbonnier, Aude
    Coiteux, Valerie
    Etienne, Gabriel
    Goldwirt, Lauriane
    Guerci-Bresler, Agnes
    Hugert, Francoise
    Legros, Laurence
    Roy, Lydia
    Nicolini, Frank Emmanuel
    BULLETIN DU CANCER, 2024, 111 (01) : 87 - 96
12345